Gastroenterology strain | Antibiotic associated diarrhea in children
Characteristics
DAILY DOSAGE IN CLINICAL STUDY
1B/5 drops or 1M/gram CFU
FUNCTIONALITY
AAD – Antibiotic associated diarrhea – Prevention [children use]
Scientific support
Human clinical trials
Corrêa, N.B., L.A. Péret Filho, F.J. Penna, F.M.S. Lima, and J.R. Nicoli. “A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants.” Journal of clinical gastroenterology 39.5 (2005): 385-389.
Antipathogenic strain I CID – Common infectious disease in children
Characteristics
DAILY DOSAGE IN CLINICAL STUDY
1B/5 drops or 1M/gram CFU
FUNCTIONALITY
CID – Common infectious disease – community acquired [children use]
Scientific support
Human clinical trial
Taipale, T., K. Pienihäkkinen, E. Isolauri, C. Larsen, E. Brockmann, P. Alanen, J. Jokela, and E. Söderling. “Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy.” British Journal of Nutrition 105.3 (2011): 409-416.
Saavedra, J.M., A. Abi-Hanna, N. Moore, and R.H. Yolken. “Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety.” The American journal of clinical nutrition 79.2 (2004): 261-267.
